Literature DB >> 3030704

Differential regulation of brain and pituitary corticotropin-releasing factor receptors by corticosterone.

R L Hauger, M A Millan, K J Catt, G Aguilera.   

Abstract

The regulatory actions of CRF during the neuroendocrine response to stress are mediated by specific receptors within the nervous system and the anterior pituitary gland. Glucocorticoids exert negative feedback inhibition on ACTH secretion by interacting at the pituitary corticotrophs and the central nervous system. To determine whether glucocorticoids influence ACTH secretion by regulating the concentration of CRF receptor sites, binding of [125I]Tyr-oCRF to pituitary and brain membrane-rich particles was studied after glucocorticoid treatment. Corticosterone administration (0.5-150 mg/day) for 1-4 days in adult male rats caused a dose-dependent decrease in the number of CRF receptors in the anterior pituitary in parallel with the reduction in ACTH secretion. In the brain, binding studies in membrane-rich fractions or by autoradiography in slide-mounted frozen sections revealed no changes in CRF receptors in the cortex, hippocampus, amygdala, septal area, and olfactory bulb, although circulating corticosterone levels were higher than during stress. The selective down-regulation of anterior pituitary CRF receptors after corticosterone administration, without alterations in brain CRF receptors, is similar to the change in CRF receptors previously reported after adrenalectomy and indicates that receptor regulatory mechanisms in secretory cells differ from those in neural tissue. Furthermore, the decrease in pituitary CRF receptors after physiological increases in circulating glucocorticoids may contribute to the inhibitory effects of adrenal steroids on ACTH secretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030704     DOI: 10.1210/endo-120-4-1527

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.

Authors:  T S Huang
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

Review 2.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

Review 3.  Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity.

Authors:  F Holsboer
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

4.  Altered regulation of gene and protein expression of hypothalamic-pituitary-adrenal axis components in an immature rat model of chronic stress.

Authors:  S Avishai-Eliner; E E Gilles; M Eghbal-Ahmadi; Y Bar-El; T Z Baram
Journal:  J Neuroendocrinol       Date:  2001-09       Impact factor: 3.627

5.  Regulation of a putative neurotransmitter effect of corticotropin-releasing factor: effects of adrenalectomy.

Authors:  L A Pavcovich; R J Valentino
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

6.  A subchronic application period of glucocorticoids leads to rat cognitive dysfunction whereas physostigmine induces a mild neuroprotection.

Authors:  Katrin Wüppen; Dirk Oesterle; Sabina Lewicka; Jürgen Kopitz; Konstanze Plaschke
Journal:  J Neural Transm (Vienna)       Date:  2010-07-27       Impact factor: 3.575

7.  Corticotropin-releasing hormone (CRH) downregulates the function of its receptor (CRF1) and induces CRF1 expression in hippocampal and cortical regions of the immature rat brain.

Authors:  Kristen L Brunson; Dimitri E Grigoriadis; Marge T Lorang; Tallie Z Baram
Journal:  Exp Neurol       Date:  2002-07       Impact factor: 5.330

8.  Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis.

Authors:  H S Chowdrey; P J Larsen; M S Harbuz; D S Jessop; G Aguilera; D J Eckland; S L Lightman
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

9.  miR-449a contributes to glucocorticoid-induced CRF-R1 downregulation in the pituitary during stress.

Authors:  Takahiro Nemoto; Asuka Mano; Tamotsu Shibasaki
Journal:  Mol Endocrinol       Date:  2013-07-26

10.  Earlier post-operative hypocortisolemia may predict durable remission from Cushing's disease.

Authors:  Natasha Ironside; Gregoire Chatain; David Asuzu; Sarah Benzo; Maya Lodish; Susmeeta Sharma; Lynnette Nieman; Constantine A Stratakis; Russell R Lonser; Prashant Chittiboina
Journal:  Eur J Endocrinol       Date:  2018-01-12       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.